Xtant Medical Holdings, Inc.XTNTNYSE
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +11.66% | +12.11% | +18.05% | +18.26% | +19.04% |
| Gross Profit Growth | +6.35% | -6.49% | +17.00% | +30.69% | +34.86% |
| EBITDA Growth | -131.37% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | -154.43% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | -151.67% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | -154.71% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +5.43% | +6.89% | +10.26% | +6.94% | +3.12% |
| Weighted Average Shares Diluted Growth | -0.42% | +6.89% | +10.09% | +14.05% | +9.97% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +7.28% | -0.34% | +9.27% | +27.21% | +24.20% |
| Inventory Growth | +22.00% | +4.74% | +0.23% | -0.92% | -2.80% |
| Asset Growth | +7.48% | +1.32% | +2.02% | +8.27% | +7.52% |
| Book Value per Share Growth | -20.69% | -21.72% | -16.54% | +0.78% | +6.86% |
| Debt Growth | +56.10% | +49.17% | +19.25% | +5.96% | -9.63% |
| R&D Expense Growth | +43.06% | +6.10% | -15.94% | -11.01% | -9.56% |
| SG&A Expenses Growth | +6.33% | -15.00% | -7.45% | -8.61% | -2.92% |